Microbio

We’re pleased to announce a strategic partnership with Shiva Scientific to expand the reach of our InfectID™-BSI test in India 🇮🇳 This agreement allows us to support healthcare providers with faster, more accurate pathogen detection, including sepsis-causing infections, helping to improve patient outcomes. Together with Shiva Scientific, we’re making strides toward a future with quicker, more effective diagnostics. Stay tuned as we continue to work towards a world where patients everywhere have access to cutting-edge solutions. #Microbio #ShivaScientific #HealthcareInnovation #InfectID #SepsisDetection #Diagnostics #IndiaHealthcare #PathogenDetection

Setting a new standard in sepsis diagnostics! 🩺 Our InfectID™-BSI (Bloodstream Infection) test detects over 94% of sepsis-causing pathogens, providing healthcare teams with the most comprehensive insights on the market. With faster, more informed diagnostics, we’re supporting critical care when it’s needed most. Curious to learn how InfectID™-BSI can make a difference? Reach out to us and follow our page to learn how our solutions are empowering faster, more informed critical care decisions. #Sepsis #Diagnostics #Healthcare #PatientCare #RapidDiagnostics #SepsisAwareness #PathogenDetection #CriticalCare

Microbio is honored to be selected for the Biomedical AI Sprints Accelerator (BASA) by ARM Hub (Advanced Robotics for Manufacturing) and MTPConnect. Together with Cortical Dynamics and Resonait Medical Technologies, we’ll leverage AI to enhance InfectID-BSI, our qPCR-based test that transforms sepsis management worldwide. This accelerator will strengthen our data capabilities, enabling us to track emerging infectious diseases and develop advanced diagnostics for better patient outcomes. A big thanks to ARM Hub and MTPConnect for this opportunity to expand our impact in healthcare innovation. #HealthcareInnovation #AI #SepsisDiagnosis #InfectID

Our InfectID™-BSI test is designed to accurately identify 26 sepsis-causing pathogens in less than 3 hours, providing healthcare providers with the critical time needed to deliver targeted treatments. In the fight against sepsis, every hour matters ⌛. Quick and precise diagnosis can significantly improve patient outcomes and potentially save lives. By reducing the time to diagnosis, we empower healthcare professionals to make informed decisions, leading to timely interventions and better care for patients facing this life-threatening condition. #Microbio #InfectIDBSI #SepsisAwareness #Sepsis #HealthcareInnovation #PatientCare

🌍 It's International Infection Prevention Week! Led by the Association for Professionals in Infection Control and Epidemiology (APIC), this week emphasizes the critical role infection prevention plays in healthcare. At Microbio, we proudly contribute to this mission with our innovative InfectID-BSI, which helps clinicians quickly identify pathogens causing bloodstream infections and improve patient outcomes. Join us in recognizing healthcare professionals and infection preventionists who work tirelessly to protect patients and prevent the spread of infections. Let's continue raising awareness and promoting practices that save lives! #IIPW2024 #InfectionPrevention #SepsisAwareness #Microbio #APIC

We are excited to welcome Katie Shepherd to the Microbio team as our new Medical Science Liaison! With 19 years of experience in clinical diagnostics and healthcare science, Katie has been dedicated to advancing public health through clinical practice and regulatory compliance. Having trained at the Royal Hampshire County Hospital, Winchester, with guidance from Consultant Microbiologist Matthew Dryden, Katie practiced as a HCPC registered Microbiology Biomedical Scientist for 11 years. Katie has also accumulated over a decade of expertise in molecular biology and has successfully established and managed a private ISO 15189-accredited clinical genomics service laboratory in the UK. Katie has not only overseen the implementation of crucial genomics services but has also played a key role in establishing Quality Management Systems (QMS) compliant with ISO 13485. Her regulatory experience spans 17 years, including 6 years focused on FDA 21 CFR Part 11 compliance. As a project lead for early access programs for innovative applications, Katie has expertly managed the launch of two significant Next Generation Sequencing (NGS) genomics solutions for the UK and European markets, showcasing her unique blend of scientific expertise and commercial strategic vision. She is deeply committed to education and mentoring, actively supporting commercial teams and nurturing long-standing relationships with key opinion leaders (KOLs). Katie is eager to bring her blend of experience, expertise and enthusiasm to the role of Medical Science Liaison with Microbio facilitating the adoption of the InfectID-BSI solution to help improve #sepsis patient outcomes.

We’re excited to announce our new partnership with ELTA 90 MGR making them our exclusive distributor in Greece! 🇬🇷    This collaboration will bring Microbio’s cutting-edge diagnostic products, including our flagship InfectID-BSI™, to healthcare providers across Greece.   With InfectID-BSI™, clinicians can identify sepsis-causing pathogens in less than 3 hours, enabling faster, targeted treatments that can significantly improve patient outcomes. This partnership marks an important step in expanding access to life-saving diagnostics throughout Europe.   We’re looking forward to working with ELTA 90 MGR, who share our commitment to innovation and excellence in healthcare.   Stay tuned for more updates on how this collaboration will help revolutionize sepsis diagnostics in Greece!   #Microbio #ELTA90MGR #HealthcareInnovation #MolecularDiagnostics #Sepsis #InfectID #Biotech #Partnerships #SavingLives

As Sepsis Awareness Month comes to a close, we want to emphasize that the fight against sepsis continues every day. Sepsis remains a leading cause of death worldwide, but early detection and rapid, targeted treatment can save lives. At Microbio, we’re committed to advancing diagnostics that support healthcare providers in identifying infections faster and more accurately with our innovative molecular diagnostic test, InfectID-BSI, which identifies 26 sepsis-associated pathogens, enabling clinicians to administer targeted treatment in under three hours. https://hubs.ly/Q02RttgP0 #SepsisAwareness #InfectID #HealthcareInnovation #PatientOutcomes #Microbio #PathogenDetection

🌍 Antimicrobial Resistance (AMR) is a global threat that requires urgent action. We commend the world leaders at #UNGA for committing to a plan to tackle this critical issue. At Microbio, we're proud to be part of the solution with InfectID-BSI, which supports the judicious use of antimicrobials and helps reduce the impact of AMR. #AMR #PublicHealth #Microbio #InfectID #PathogenDetection

Antimicrobial Resistance: A Growing Global Threat 🌍 By 2050, over 39 million lives are projected to be lost to antimicrobial-resistant (AMR) infections, according to a new global study. AMR, which can affect anyone regardless of age, is rising at alarming rates, complicating the treatment of common infections. The good news? Action now can save lives. Improved access to healthcare and antibiotics could prevent up to 92 million deaths by mid-century. At Microbio, we are committed to advancing innovative diagnostics to detect infections early and help mitigate the growing AMR crisis. 🔗 Read more: https://hubs.ly/Q02QKn0K0 #AMR #PublicHealth #AntibioticResistance #Healthcare #InfectionControl #Innovation #Microbio